.
BioEnterprise

AlgiSys

AlgiSys is developing a low cost, fermentation-based production process for commercially important omega-3 fatty acids. The proprietary process will be scalable and commercial production is planned within 3 years.

Funding

Angel Investors

Stage

Clinical